Trademark: 87751543
Word
MULTIVIR
Status Date
Monday, January 27, 2020
Filing Date
Thursday, January 11, 2018
Abandoned Date
Friday, January 17, 2020
42 Gene therapy based pharmaceutical drug research and development in the field of biotech therapeutics; development of gene therapy-based pharmaceutical drugs and therapeutic compounds; development of drugs for the pharmaceutical and biotech industries for the treatment of a wide variety of diseases and other conditions, namely, cancer and other hyperproliferative disorders; Scientific and technological research services in the field of biomarker profiles predicting gene therapy efficacy; providing "in vitro" and "in vivo" preclinical and clinical testing of gene therapy products for scientific, research, healthcare, product development, consulting, and educational purposes
Color is not claimed as a feature of the mark.
The mark consists of the word "MULTIVIR" in upper and lower case letters with a double helix on the right side.
Jan 27, 2020
Abandonment Notice E-Mailed - Failure To Respond
Jan 27, 2020
Abandonment - Failure To Respond Or Late Response
Jul 16, 2019
Notification Of Non-Final Action E-Mailed
Jul 16, 2019
Non-Final Action E-Mailed
Jul 16, 2019
Non-Final Action Written
Jun 18, 2019
Teas/Email Correspondence Entered
Jun 17, 2019
Correspondence Received In Law Office
Jun 17, 2019
Teas Response To Office Action Received
Dec 17, 2018
Notification Of Priority Action E-Mailed
Dec 17, 2018
Priority Action E-Mailed
Dec 17, 2018
Priority Action Written
Nov 7, 2018
Teas/Email Correspondence Entered
Nov 7, 2018
Correspondence Received In Law Office
Oct 29, 2018
Assigned To Lie
Oct 17, 2018
Teas Response To Office Action Received
Apr 18, 2018
Notification Of Non-Final Action E-Mailed
Apr 18, 2018
Non-Final Action E-Mailed
Apr 18, 2018
Non-Final Action Written
Apr 11, 2018
Assigned To Examiner
Jan 26, 2018
Notice Of Design Search Code E-Mailed
Jan 25, 2018
New Application Office Supplied Data Entered In Tram
Jan 15, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
